Form 4 Tracker
Struthers Richard Scott

Director, President & CEO · 2 filings · Latest: Mar 16, 2026

Crinetics Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CRNX
Struthers Richard ScottDirector, President & CEOMar 16, 2026
Sale
$37.3721,981$821.5K404,778
CRNX
Richard Scott StruthersMar 16, 2026
Proposed Sale
$37.4945,013$1.7M
CRNX
Struthers Richard ScottSep 26, 2025
Proposed Sale
$45.004,000$180.0K
CRNX
Struthers Richard ScottDec 2, 2024
Proposed Sale
$57.2710,000$572.7K